Response by Blanton et al to Letter Regarding Article, "Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After LVAD Implantation: An INTERMACS Analysis"

Circ Heart Fail. 2019 Sep;12(9):e006465. doi: 10.1161/CIRCHEARTFAILURE.119.006465. Epub 2019 Sep 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Heart Failure*
  • Heart-Assist Devices*
  • Humans
  • Phosphodiesterase 5 Inhibitors
  • Registries

Substances

  • Phosphodiesterase 5 Inhibitors
  • Cyclic Nucleotide Phosphodiesterases, Type 5